The legal battle between Apple and medical technology company Masimo continues, with the bigger company — sort of — winning the latest face-off. A federal jury agreed with Apple that earlier versions of Masimo’s W1 and Freedom watches (pictured above) infringed its design patents. Reuters. He paid Apple only $250 in damages, the smallest amount that can be awarded for patent infringement, but the company’s lawyers told the court that it was not after the money anyway.
What Apple, worth $3.5 trillion, wanted was a ban on sales of Masimo’s current smartwatch models. However, the jury found that these new models did not infringe Apple’s intellectual property. That’s why Masimo hailed the jury’s decision as a victory, telling the news organization that it was grateful for a verdict “in favor of Masimo and against Apple on almost all counts.” As it turns out, the decision only applies to the “internally suspended module and charger”. As for Apple, he said Reuters I’m glad the jury’s decision today will protect innovation [it advances] on behalf of [its] customers.”
Masimo sued Apple in 2021, accusing it of infringing several patents for light-based blood-oxygen monitoring, and the tech giant countersued a year later. Court He moved to Massimo’s side It forced Apple in 2023 stop sales on the latest smartwatch modelsLike the US International Trade Commission blocked all Watch Series 9 and Ultra 2 are imported into the country. The company applied and was eventually able to sell its watches in the country earlier this year elimination of technology Of the units offered in the US.
